Boxer Capital as of March 31, 2022
Portfolio Holdings for Boxer Capital
Boxer Capital holds 74 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 8.5 | $164M | 2.0M | 82.22 | |
| Springworks Therapeutics (SWTX) | 6.0 | $117M | 2.1M | 56.44 | |
| Iteos Therapeutics | 5.3 | $103M | 3.2M | 32.18 | |
| BeiGene Sponsored Adr (ONC) | 4.8 | $94M | 500k | 188.60 | |
| Revolution Medicines (RVMD) | 4.6 | $89M | 3.5M | 25.51 | |
| Relay Therapeutics (RLAY) | 4.1 | $80M | 2.7M | 29.93 | |
| Cytokinetics Com New (CYTK) | 4.0 | $77M | 2.1M | 36.81 | |
| Pmv Pharmaceuticals (PMVP) | 3.7 | $73M | 3.5M | 20.82 | |
| Tyra Biosciences (TYRA) | 3.5 | $69M | 6.4M | 10.70 | |
| Apellis Pharmaceuticals (APLS) | 3.4 | $66M | 1.3M | 50.81 | |
| Prometheus Biosciences | 3.3 | $65M | 1.7M | 37.76 | |
| Spdr Ser Tr S&p Biotech (XBI) | 3.2 | $63M | 700k | 89.88 | |
| Tango Therapeutics (TNGX) | 2.7 | $52M | 6.9M | 7.58 | |
| Merus N V (MRUS) | 2.6 | $50M | 1.9M | 26.44 | |
| Arcus Biosciences Incorporated (RCUS) | 2.3 | $45M | 1.4M | 31.56 | |
| Reata Pharmaceuticals Cl A | 2.1 | $41M | 1.2M | 32.76 | |
| Sage Therapeutics (SAGE) | 1.9 | $36M | 1.1M | 33.10 | |
| Blueprint Medicines (BPMC) | 1.7 | $32M | 507k | 63.88 | |
| Iovance Biotherapeutics (IOVA) | 1.7 | $32M | 1.9M | 16.65 | |
| Anaptysbio Inc Common (ANAB) | 1.7 | $32M | 1.3M | 24.74 | |
| ACADIA Pharmaceuticals (ACAD) | 1.6 | $31M | 1.3M | 24.19 | |
| Amylyx Pharmaceuticals (AMLX) | 1.5 | $28M | 2.2M | 12.85 | |
| Ideaya Biosciences (IDYA) | 1.3 | $25M | 2.2M | 11.19 | |
| Rocket Pharmaceuticals (RCKT) | 1.2 | $23M | 1.5M | 15.86 | |
| Nuvation Bio Com Cl A (NUVB) | 1.2 | $23M | 4.3M | 5.26 | |
| Amicus Therapeutics (FOLD) | 1.1 | $22M | 2.3M | 9.47 | |
| Bellus Health Com New | 1.1 | $22M | 3.2M | 6.88 | |
| Gossamer Bio (GOSS) | 1.1 | $21M | 2.5M | 8.68 | |
| Kinnate Biopharma | 1.1 | $21M | 1.8M | 11.26 | |
| Avidity Biosciences Ord (RNA) | 1.1 | $21M | 1.1M | 18.47 | |
| Point Biopharma Global | 1.0 | $20M | 2.5M | 7.97 | |
| Fate Therapeutics (FATE) | 1.0 | $19M | 500k | 38.77 | |
| GH Research Ordinary Shares (GHRS) | 1.0 | $19M | 1.0M | 18.29 | |
| Xenon Pharmaceuticals (XENE) | 0.9 | $18M | 600k | 30.57 | |
| Nurix Therapeutics (NRIX) | 0.9 | $17M | 1.2M | 14.01 | |
| Nuvalent Inc-a (NUVL) | 0.9 | $17M | 1.2M | 13.89 | |
| Ultragenyx Pharmaceutical (RARE) | 0.7 | $15M | 200k | 72.62 | |
| Milestone Pharmaceuticals (MIST) | 0.7 | $14M | 2.2M | 6.42 | |
| Day One Biopharmaceuticals I (DAWN) | 0.6 | $12M | 1.2M | 9.92 | |
| Akero Therapeutics (AKRO) | 0.6 | $12M | 832k | 14.19 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.6 | $11M | 1.3M | 9.01 | |
| Cullinan Oncology (CGEM) | 0.6 | $11M | 1.1M | 10.47 | |
| Prothena Corp SHS (PRTA) | 0.6 | $11M | 300k | 36.57 | |
| Turning Point Therapeutics I | 0.6 | $11M | 400k | 26.85 | |
| Theseus Pharmaceuticals | 0.5 | $10M | 892k | 11.53 | |
| 2Seventy Bio Common Stock | 0.4 | $7.8M | 460k | 17.06 | |
| Ngm Biopharmaceuticals | 0.4 | $7.6M | 500k | 15.25 | |
| Atreca Cl A Com (BCEL) | 0.4 | $7.0M | 2.2M | 3.17 | |
| Solid Biosciences | 0.3 | $6.4M | 5.3M | 1.20 | |
| Rain Therapeutics | 0.3 | $6.0M | 1.2M | 5.07 | |
| Oric Pharmaceuticals (ORIC) | 0.3 | $5.6M | 1.1M | 5.34 | |
| Black Diamond Therapeutics (BDTX) | 0.3 | $5.6M | 2.0M | 2.77 | |
| Odonate Therapeutics Ord | 0.3 | $5.6M | 4.2M | 1.32 | |
| Codiak Biosciences | 0.3 | $5.3M | 850k | 6.27 | |
| Biomea Fusion (BMEA) | 0.3 | $5.3M | 1.2M | 4.46 | |
| BCLS Acquisition Corp Com Cl A | 0.3 | $4.9M | 500k | 9.87 | |
| Panacea Acquisition Corp II Cl A Shs | 0.3 | $4.9M | 500k | 9.75 | |
| Essa Pharma Com New (EPIX) | 0.2 | $4.5M | 725k | 6.19 | |
| Eqrx | 0.2 | $4.1M | 1.0M | 4.13 | |
| Selecta Biosciences | 0.2 | $4.0M | 3.3M | 1.23 | |
| Health Sciences Acq Corp II Ord Shs | 0.2 | $4.0M | 400k | 9.91 | |
| Bioatla (BCAB) | 0.2 | $3.5M | 686k | 5.03 | |
| DBV Technologies SA Sponsored Adr | 0.2 | $3.4M | 2.1M | 1.59 | |
| Aligos Therapeutics | 0.2 | $3.3M | 1.5M | 2.15 | |
| Elevation Oncology (ELEV) | 0.1 | $2.2M | 873k | 2.52 | |
| Omega Alpha SPAC Cl A | 0.1 | $2.0M | 200k | 9.82 | |
| Gemini Therapeutics | 0.1 | $1.8M | 1.3M | 1.39 | |
| MEI Pharma Com New | 0.1 | $1.8M | 2.9M | 0.60 | |
| Genocea Biosciences Com New (GNCAQ) | 0.1 | $1.4M | 1.1M | 1.25 | |
| Cabaletta Bio (CABA) | 0.1 | $1.1M | 540k | 2.03 | |
| Protara Therapeutics Com Stk (TARA) | 0.1 | $1.1M | 209k | 5.11 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $203k | 267k | 0.76 | |
| Bellicum Pharmaceuticals Com New | 0.0 | $123k | 57k | 2.16 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $17k | 67k | 0.26 |